MarketInOut Stock Screener Log In | Sign Up

Anthem Biosciences Ltd

BSE • Healthcare • Biotechnology • Quote as of 10/27/2026 15:53
Anthem Biosciences Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBSE
Market Capitalization457,669 mln
Float107 mln

EPS

10.02
Stretched

P / E

83.50
Speculative

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.42
Borderline

1-Year Forecast

920.12
Modest upside

Relative Strength

43 / 100
Slightly lagging

Business Description

Anthem Biosciences, founded in 2006 and headquartered in Bengaluru, India, helps pharmaceutical companies develop and manufacture complex medicines from early research through to commercial production. The company supports drug programs involving biologics, peptides, RNA therapies, and other advanced treatments, handling everything from initial discovery to large-scale manufacturing. It also produces and sells specialty ingredients, including fermentation-based pharmaceutical actives, probiotics, enzymes, and nutritional compounds.

Key Fundamentals

EPS10.02
P/E83.50
ROE21.06
RPS35.71
ROIC22.76
ROA18.15
Interest Cover106
EBITDA, mln9,264
EV / EBITDA52.41
EV / EBIT61.55
Revenue, mln20,023
EV / Revenue24.25

Quote Details

Last 836.70
Change 17.6 (2.15%)
Open 822.50
Volume 20,149
Turnover 16,858,668
Average Volume 252,879

Financial Ratios

Pre-Tax Profit Margin39
Current Ratio5.54
Price / Book15.80
Price / Tangible Book15.80
Price / Free Cash Flow68.80
Debt / Equity0.02
Price / Sales24.25

Financial Strength

Altman Z-Score78.9
Piotroski F-Score 7 / 9
Beneish M-Score-2.42
Price to Graham Number7.47
1-Year Target Price920.12

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.49% 90 / 100   
1 Month -5.38% 58 / 100   
2 Months 5.7% 77 / 100   
6 Months 13.36% 76 / 100   
1 Year 8.73% 78 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog